<DOC>
	<DOCNO>NCT02146157</DOCNO>
	<brief_summary>This multi-center , randomize , double-blind , placebo-controlled study approximately 104 subject ( 52 per group ) evaluate effectiveness herb mineral combination product fast serum glucose level subject impair fast glucose . The study consist 5 visit : Screening visit , follow Baseline visit ( eligible subject randomize product consume throughout 12-week supplementation period ) , follow Supplementation period visit 3 , 6 12 week baseline .</brief_summary>
	<brief_title>Trial Herb Mineral Combination Product Fasting Glucose Adults Risk Developing Diabetes</brief_title>
	<detailed_description>The target population clinical trial otherwise healthy , pre-diabetic adult present impaired fasting glucose .</detailed_description>
	<mesh_term>Prediabetic State</mesh_term>
	<criteria>Be male female , least 18 year age If age ≥45 year , must body mass index ≥ 25 kg/m2 If age &lt; 45 year , must body mass index ≥ 25 kg/m2 AND present least one additional risk factor develop diabetes . Agree use contraception throughout study period , unless postmenopausal surgically sterile ( woman ) Be able understand nature purpose study include potential risk side effect Be willing consent study participation comply study requirement Have finger stick fast blood glucose 105 140 mg/dL serum fast glucose 100 125 mg/dL , measure screening Have diabetes ( type I II ) HBA1c measurement &gt; 6.5 % time past screen visit Have take within 2 week screen dietary supplement include vitamin mineral complex ; herbal supplement ; fish oil ; fiber supplement ; herbal ingredient/product significantly affect glucose metabolism Have take within 4 week screen prescription overthecounter ( OTC ) medication significantly affect glucose metabolism , include limited , sulfonylureas , meglitinides , biguanides , thiazolidinediones , alphaglucosidase inhibitor , Inhibitors dipeptidyl peptidase 4 ( DPP4 inhibitor ) , systemic corticosteroid Daily use nonsteroidal antiinflammatory drug ( NSAIDS ) ( daily baby aspirin use continuous use NSAIDS 3 day less acute ache pain acceptable ) Any comorbidity treatment could , opinion investigator , preclude subject 's ability successfully safely complete study may confound study outcomes Anticipated change dietary pattern physical activity level study , include attempt body weight reduction Eating disorder Polycystic ovary syndrome Known allergy intolerance substance study product Are pregnant breastfeed woman History alcohol , drug , medication abuse Have participate another study investigational product within 1 month screening Had recent ( &lt; 3 month ) gastrointestinal surgery plan surgery clinical study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>